30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Karuna Therapeutics Inc. (KRTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | HBK Investments David Costen Haley | 0 | $0 | 0% | |
| 2. | Squarepoint Ops LLC Maxime Fortin (Cio) | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | ||
| 4. | 0 | $0 | 0% | ||
| 5. | First Turn Management Lisa Wheatley | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $123.39 | 24,161 | $2,981,225.79 | 2,072,441 | 2022-06-30 | Filing | |
| $122.27 | 48,062 | $5,876,540.74 | 2,048,280 | 2022-06-30 | Filing | |
| $125.00 | 9,129 | $1,141,125.00 | 2,000,218 | 2022-06-29 | Filing | |
| $124.73 | 6,832 | $852,155.36 | 1,991,089 | 2022-06-29 | Filing | |
| $122.95 | 4,039 | $496,595.05 | 1,984,257 | 2022-06-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $318.96 | 100 | $31,896.00 | 42,604 | 2024-03-08 | Filing | |
| $318.33 | 4,900 | $1,559,817.00 | 42,704 | 2024-03-08 | Filing | |
| $316.56 | 818 | $258,946.08 | 41,150 | 2024-02-08 | Filing | |
| $316.05 | 4,182 | $1,321,721.10 | 41,968 | 2024-02-08 | Filing | |
| $316.81 | 15,000 | $4,752,150.00 | 38,650 | 2024-01-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% |
News See All
Bronte Amalthea Fund Incurred Loss in Karuna Therapeutics (KRTX) Short Position
Bronte Capital, an investment management company, released its “Amalthea Fund” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Karuna Therapeutics (KRTX) Rose on Acquisition Announcement
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Karuna Therapeutics Third Quarter 2023 Financial Results Conference Call. All participants are in a listen-only mode. Please note, this call is being recorded.
What Makes Karuna Therapeutics (KRTX) a Prospective Investment?
ClearBridge Investments, an investment management company, released its “ClearBridge SMID Cap Growth Strategy” second quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Best High Risk High Reward Stocks To Buy Now
In this piece, we will take a look at the five best high risk high reward stocks to buy now.
10 Oversold Healthcare Stocks to Buy
In this article, we will take a look at the 10 healthcare stocks to buy.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Karuna Therapeutics Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note that this call is being recorded.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Q1 2023 Earnings Call Transcript
Operator: Welcome to the Karuna Therapeutics First Quarter 2023 Financial Results Conference Call. All participants are in a listen-only mode. Please note this call is being recorded.
11 Best Mid-Cap Healthcare Stocks To Buy Now
The healthcare industry outlook is currently uncertain due to a combination of factors such as economic troubles, a shortage of healthcare workers, and the ongoing COVID-19 pandemic.
Billionaire Hedge Funds
